PL145814B1 - Method of obtaining novel condensed derivatives of double-ring imidazole - Google Patents

Method of obtaining novel condensed derivatives of double-ring imidazole Download PDF

Info

Publication number: PL145814B1
Authority: PL; Poland
Prior art keywords: compounds; pyridine; formula; evaporated; alkyl
Prior art date: 1984-06-20

Application number

PL1985259305A

Other languages

English (en)

Polish (pl)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-20

Filing date

1985-06-20

Publication date

1988-11-30

1985-06-20 Application filed filed Critical

1988-11-30 Publication of PL145814B1 publication Critical patent/PL145814B1/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

PL1985259305A 1984-06-20 1985-06-20 Method of obtaining novel condensed derivatives of double-ring imidazole PL145814B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/622,421 US4617307A (en)	1984-06-20	1984-06-20	Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors

Publications (1)

Publication Number	Publication Date
PL145814B1 true PL145814B1 (en)	1988-11-30

Family

ID=24494112

Family Applications (6)

Application Number	Title	Priority Date	Filing Date
PL1985259305A PL145814B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel condensed derivatives of double-ring imidazole
PL1985259307A PL145105B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259303A PL145103B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985254099A PL145087B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel derivatives of imidazo /1,5-a/ pyridine
PL1985259304A PL145348B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel condensed disubstituted imidazole derivatives
PL1985259306A PL145104B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel concentrated two-ring derivatives of imidazole

Family Applications After (5)

Application Number	Title	Priority Date	Filing Date
PL1985259307A PL145105B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259303A PL145103B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985254099A PL145087B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel derivatives of imidazo /1,5-a/ pyridine
PL1985259304A PL145348B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel condensed disubstituted imidazole derivatives
PL1985259306A PL145104B1 (en)	1984-06-20	1985-06-20	Method of obtaining novel concentrated two-ring derivatives of imidazole

Country Status (31)

Country	Link
US (1)	US4617307A (2)
EP (1)	EP0165904B1 (2)
JP (1)	JPS6112688A (2)
KR (1)	KR900008566B1 (2)
AT (1)	ATE62415T1 (2)
AU (1)	AU589565B2 (2)
BG (7)	BG60262B2 (2)
CA (1)	CA1276633C (2)
CS (1)	CS268672B2 (2)
CY (1)	CY1750A (2)
DD (1)	DD237510A5 (2)
DE (1)	DE3582452D1 (2)
DK (1)	DK170302B1 (2)
DZ (1)	DZ799A1 (2)
ES (6)	ES8702406A1 (2)
FI (1)	FI80694C (2)
GR (1)	GR851487B (2)
HK (1)	HK23494A (2)
HU (1)	HU202529B (2)
IE (1)	IE58070B1 (2)
IL (1)	IL75546A (2)
MA (1)	MA20459A1 (2)
MX (1)	MX9203369A (2)
NO (1)	NO162467C (2)
NZ (1)	NZ212483A (2)
PH (1)	PH23390A (2)
PL (6)	PL145814B1 (2)
PT (1)	PT80661B (2)
RO (1)	RO92583A (2)
SU (6)	SU1433413A3 (2)
ZA (1)	ZA854615B (2)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5428160A (en) *	1982-12-21	1995-06-27	Ciba-Geigy Corporation	Substituted imidazo[5-a]pyridine derviatives and other substituted bicyclic derivatives
US4728645A (en) *	1982-12-21	1988-03-01	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4889861A (en) *	1982-12-21	1989-12-26	Ciba-Geigy Corp.	Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
GB8510541D0 (en) *	1985-04-25	1985-05-30	Wyeth John & Brother Ltd	Heterocyclic compounds
US5171858A (en) *	1985-06-05	1992-12-15	Schering A.G.	Preparation of certain 5,6-dihydro-8-phenyl-imidazo[1,5-a]pyridines
US4978672A (en) *	1986-03-07	1990-12-18	Ciba-Geigy Corporation	Alpha-heterocyclc substituted tolunitriles
US4749713A (en) *	1986-03-07	1988-06-07	Ciba-Geigy Corporation	Alpha-heterocycle substituted tolunitriles
US4937250A (en) *	1988-03-07	1990-06-26	Ciba-Geigy Corporation	Alpha-heterocycle substituted tolunitriles
US4797411A (en) *	1986-07-18	1989-01-10	Farmitalia Carlo Erba S.P.A.	Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
GB8820730D0 (en) *	1988-09-02	1988-10-05	Erba Carlo Spa	Substituted 5 6 7 8-tetrahydroimidazo/1.5-a/pyridines & process for their preparation
US5057521A (en) *	1988-10-26	1991-10-15	Ciba-Geigy Corporation	Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
US5066656A (en) *	1989-11-01	1991-11-19	Janssen Pharmaceutica N.V.	Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
CA2026792A1 (en) *	1989-11-01	1991-05-02	Michael N. Greco	(6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
MTP1076B (en) *	1990-01-12	1991-09-30	Ciba Geigy Ag	Hemihydrate
US5162337A (en) *	1990-10-05	1992-11-10	Merck & Co., Inc.	Animal growth promotion
EP0514015A1 (en) *	1991-04-19	1992-11-19	Merck & Co. Inc.	Control of sex differentiation in fish
CH683151A5 (de) *	1991-04-24	1994-01-31	Ciba Geigy Ag	Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
JPH05176659A (ja) *	1991-04-26	1993-07-20	Merck & Co Inc	家禽における雌性表現型を転換するために抗ミュラー管ホルモンを単独またはアロマターゼ阻害剤と組合せて使用する方法
AU2356195A (en) *	1994-04-14	1995-11-10	Sepracor, Inc.	Treating estrogen-dependent diseases with (-)-fadrozole
AU682947B2 (en) *	1994-05-27	1997-10-23	Mochida Pharmaceutical Co., Ltd.	Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
DE4432106A1 (de) *	1994-09-09	1996-03-14	Hoechst Ag	Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
AU2003250190A1 (en) *	2002-07-30	2004-02-23	Novartis Ag	Combination of an aromatase inhibitor with a bisphosphonate
EP1537114B8 (en) *	2002-08-07	2007-10-03	Novartis AG	Organic compounds as agents for the treatment of aldosterone mediated conditions
WO2004046145A1 (en) *	2002-11-18	2004-06-03	Novartis Ag	Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
WO2005007627A1 (ja) *	2003-07-18	2005-01-27	Nihon Nohyaku Co., Ltd.	フェニルピリジン誘導体、その中間体及びこれを有効成分とする除草剤
GB0327839D0 (en)	2003-12-01	2003-12-31	Novartis Ag	Organic compounds
NZ549535A (en)	2004-03-17	2010-11-26	Novartis Ag	Use of aliskiren for treating renal and other disorders
CN1997643A (zh) *	2004-05-28	2007-07-11	斯皮德尔实验股份公司	杂环化合物及其作为醛固酮合酶抑制剂的应用
CA2568159A1 (en) *	2004-05-28	2005-12-15	Speedel Experimenta Ag	Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
GT200600381A (es)	2005-08-25	2007-03-28		Compuestos organicos
EP1842543A1 (en)	2006-04-05	2007-10-10	Speedel Pharma AG	Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
MX2008015008A (es) *	2006-05-26	2008-12-05	Novartis Ag	INHIBIDORES DE SINTASA DE ALDOSTERONA Y/O DE 11ß-HIDROXILASA.
CA2657258A1 (en)	2006-07-20	2008-01-24	Novartis Ag	Amino-piperidine derivatives as cetp inhibitors
JP2010501573A (ja) *	2006-08-25	2010-01-21	ノバルティスアクチエンゲゼルシャフト	アルドステロン合成酵素および／または１１−β−ヒドロキシラーゼおよび／またはアロマターゼが介在する疾患の処置のための縮合イミダゾール誘導体
WO2008085302A1 (en) *	2006-12-20	2008-07-17	Merck & Co., Inc.	Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
EP2463282B1 (en)	2007-11-05	2013-08-07	Novartis AG	4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
MX2010006063A (es)	2007-12-03	2010-07-01	Novartis Ag	Derivados de 4-bencil-amino-pirrolidina 1,2-disustituida como inhibidores de la proteina de transferencia de colesteril-ester (cetp) utiles para el tratamiento de las enfermedades tales como hiperlipidemia o arterioesclerosis.
EP2095819A1 (en) *	2008-02-28	2009-09-02	Maastricht University	N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
CN103896796B (zh)	2009-05-28	2016-04-27	诺华股份有限公司	作为脑啡肽酶抑制剂的取代的氨基丙酸衍生物
EP2435402B1 (en)	2009-05-28	2016-04-13	Novartis AG	Substituted aminobutyric derivatives as neprilysin inhibitors
JO2967B1 (en)	2009-11-20	2016-03-15	نوفارتس ايه جي	Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US8877815B2 (en)	2010-11-16	2014-11-04	Novartis Ag	Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8673974B2 (en)	2010-11-16	2014-03-18	Novartis Ag	Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
AR086665A1 (es)	2011-06-14	2014-01-15	Lilly Co Eli	Inhibidor de aldosterona sintasa y composiciones farmaceuticas
ES2683350T3 (es)	2011-07-08	2018-09-26	Novartis Ag	Método para tratar la aterosclerosis en sujetos con alto nivel de triglicéridos
JO3137B1 (ar)	2012-01-17	2017-09-20	Novartis Ag	أملاح وأشكال جديدة لمثبط إنزيم سينثاز أو أروماتاز ثنائي هيدروبيرولو [2،1-c] إيميدازوليل ألدوستيرون
UY35144A (es)	2012-11-20	2014-06-30	Novartis Ag	Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
CU24330B1 (es)	2013-02-14	2018-03-13	Novartis Ag	Derivados del ácido 4-((1,1) bifenil-4-il)-3-(3-fosfonopropanamido) butanoico, activos como inhibidores de nep (endopeptidasa neutral)
MX2016001020A (es)	2013-07-25	2016-08-03	Novartis Ag	Polipeptidos ciclicos para el tratamiento de insuficiencia cardiaca.
CN105705167A (zh)	2013-07-25	2016-06-22	诺华股份有限公司	合成的apelin多肽的生物缀合物
CR20170338A (es)	2015-01-23	2017-09-12	Novartis Ag	Conjugados de ácidos grasos y apelina sintética con mayor vida media
MX2017009839A (es) *	2015-01-29	2017-11-02	Novartis Ag	Proceso para la produccion de derivados de imidazolo condensados.
GB201511790D0 (en)	2015-07-06	2015-08-19	Iomet Pharma Ltd	Pharmaceutical compound
JP2016074729A (ja) *	2015-12-31	2016-05-12	国立大学法人千葉大学	イミダゾリウム塩及びそれを用いた不斉合成触媒並びにイミダゾリウム塩の製造方法
JOP20190086A1 (ar)	2016-10-21	2019-04-18	Novartis Ag	مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
CN109890389B (zh) *	2016-10-27	2022-07-01	达米安制药股份公司	醛固酮合酶抑制剂
WO2018078049A1 (en)	2016-10-27	2018-05-03	Damian Pharma Ag	Aldosterone synthase inhibitor
UY38072A (es)	2018-02-07	2019-10-01	Novartis Ag	Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
JP7470050B2 (ja)	2018-05-03	2024-04-17	ダミアンファーマアーゲー	アルドステロン症の治療における使用のためのｒ－ファドロゾール
JP7657151B2 (ja)	2018-11-27	2025-04-04	ノバルティスアーゲー	代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン／ケキシン９型（ｐｃｓｋ９）阻害剤としての環状ペプチド
US20230089867A1 (en)	2018-11-27	2023-03-23	Novartis Ag	Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorder
UY38485A (es)	2018-11-27	2020-06-30	Novartis Ag	Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
WO2023084449A1 (en)	2021-11-12	2023-05-19	Novartis Ag	Diaminocyclopentylpyridine derivatives for the treatment of a disease or disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5124517B1 (2) *	1971-03-15	1976-07-24
FR2449689A1 (fr) *	1979-02-20	1980-09-19	Logeais Labor Jacques	Nouveaux derives condenses de pyrrolidine ou de piperidine, leur procede de preparation et leurs applications en therapeutique
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
FI75569C (fi) *	1981-06-22	1988-07-11	Ciba Geigy Ag	Analogifoerfarande foer framstaellning av terapeutiskt verkande imidazo/1,5-a/pyridiner.
US4409226A (en) *	1981-10-05	1983-10-11	Schering Corporation	Imidazo[1,5-a]pyridines
US4361567A (en) *	1981-10-05	1982-11-30	Schering Corporation	Treatment of peptic ulcer disease
US4588732A (en) *	1982-12-21	1986-05-13	Ciba-Geigy Corporation	Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) *	1982-12-21	1984-09-11	Ciba-Geigy Corporation	Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors

1984
- 1984-06-20 US US06/622,421 patent/US4617307A/en not_active Expired - Lifetime
1985
- 1985-06-17 AT AT85810279T patent/ATE62415T1/de not_active IP Right Cessation
- 1985-06-17 EP EP85810279A patent/EP0165904B1/de not_active Expired - Lifetime
- 1985-06-17 DE DE8585810279T patent/DE3582452D1/de not_active Expired - Lifetime
- 1985-06-17 FI FI852399A patent/FI80694C/fi not_active IP Right Cessation
- 1985-06-18 CA CA000484263A patent/CA1276633C/en not_active Expired - Lifetime
- 1985-06-18 DZ DZ850130A patent/DZ799A1/fr active
- 1985-06-18 GR GR851487A patent/GR851487B/el unknown
- 1985-06-18 IL IL75546A patent/IL75546A/xx not_active IP Right Cessation
- 1985-06-18 CS CS854449A patent/CS268672B2/cs not_active IP Right Cessation
- 1985-06-19 RO RO85119210A patent/RO92583A/ro unknown
- 1985-06-19 PH PH32427A patent/PH23390A/en unknown
- 1985-06-19 PT PT80661A patent/PT80661B/pt unknown
- 1985-06-19 DK DK277685A patent/DK170302B1/da not_active IP Right Cessation
- 1985-06-19 ZA ZA854615A patent/ZA854615B/xx unknown
- 1985-06-19 AU AU43857/85A patent/AU589565B2/en not_active Expired
- 1985-06-19 HU HU852417A patent/HU202529B/hu unknown
- 1985-06-19 IE IE152085A patent/IE58070B1/en not_active IP Right Cessation
- 1985-06-19 ES ES544344A patent/ES8702406A1/es not_active Expired
- 1985-06-19 KR KR1019850004323A patent/KR900008566B1/ko not_active Expired
- 1985-06-19 MA MA20686A patent/MA20459A1/fr unknown
- 1985-06-19 NZ NZ212483A patent/NZ212483A/xx unknown
- 1985-06-19 SU SU853917403A patent/SU1433413A3/ru active
- 1985-06-19 BG BG70749A patent/BG60262B2/xx unknown
- 1985-06-19 NO NO852474A patent/NO162467C/no unknown
- 1985-06-20 PL PL1985259305A patent/PL145814B1/pl unknown
- 1985-06-20 JP JP60133167A patent/JPS6112688A/ja active Granted
- 1985-06-20 PL PL1985259307A patent/PL145105B1/pl unknown
- 1985-06-20 PL PL1985259303A patent/PL145103B1/pl unknown
- 1985-06-20 PL PL1985254099A patent/PL145087B1/pl unknown
- 1985-06-20 PL PL1985259304A patent/PL145348B1/pl unknown
- 1985-06-20 DD DD85277587A patent/DD237510A5/de not_active IP Right Cessation
- 1985-06-20 PL PL1985259306A patent/PL145104B1/pl unknown
1986
- 1986-05-30 ES ES555542A patent/ES8802049A1/es not_active Expired
- 1986-05-30 ES ES555538A patent/ES8802048A1/es not_active Expired
- 1986-05-30 ES ES555540A patent/ES8801262A1/es not_active Expired
- 1986-05-30 ES ES555539A patent/ES8802155A1/es not_active Expired
- 1986-05-30 ES ES555541A patent/ES8800681A1/es not_active Expired
- 1986-07-02 SU SU864027755A patent/SU1436879A3/ru active
- 1986-07-02 SU SU864027757A patent/SU1436880A3/ru active
- 1986-07-02 SU SU864027756A patent/SU1482530A3/ru active
- 1986-07-02 SU SU864027758A patent/SU1443802A3/ru active
- 1986-07-02 SU SU864027754A patent/SU1436878A3/ru active
1992
- 1992-06-25 MX MX9203369A patent/MX9203369A/es unknown
- 1992-10-22 BG BG097009A patent/BG60305B2/bg unknown
- 1992-10-22 BG BG097010A patent/BG60306B2/bg unknown
- 1992-10-22 BG BG097011A patent/BG60307B2/xx unknown
- 1992-10-22 BG BG097012A patent/BG60352B2/bg unknown
- 1992-10-22 BG BG097013A patent/BG60353B2/bg unknown
1993
- 1993-11-11 BG BG098213A patent/BG60402B2/bg unknown
1994
- 1994-03-17 HK HK234/94A patent/HK23494A/xx not_active IP Right Cessation
- 1994-06-03 CY CY175094A patent/CY1750A/xx unknown

Also Published As

Publication number	Publication date
FI852399A0 (fi)	1985-06-17
ATE62415T1 (de)	1991-04-15
ES8802049A1 (es)	1988-03-16
CA1276633C (en)	1990-11-20
DD237510A5 (de)	1986-07-16
BG60353B2 (bg)	1994-11-30
ES8802048A1 (es)	1988-03-16
PL145105B1 (en)	1988-08-31
ES555540A0 (es)	1987-12-16
SU1436878A3 (ru)	1988-11-07
ES555538A0 (es)	1988-03-16
SU1433413A3 (ru)	1988-10-23
HK23494A (en)	1994-03-25
MX9203369A (es)	1992-09-01
US4617307A (en)	1986-10-14
DZ799A1 (fr)	2004-09-13
KR860000299A (ko)	1986-01-27
ZA854615B (en)	1986-02-26
MA20459A1 (fr)	1985-12-31
ES8801262A1 (es)	1987-12-16
FI80694C (fi)	1990-07-10
ES8802155A1 (es)	1988-04-01
NZ212483A (en)	1988-10-28
EP0165904B1 (de)	1991-04-10
ES555542A0 (es)	1988-03-16
SU1436880A3 (ru)	1988-11-07
EP0165904A3 (en)	1987-09-09
HUT37936A (en)	1986-03-28
DK277685A (da)	1985-12-21
AU589565B2 (en)	1989-10-19
PH23390A (en)	1989-07-26
BG60307B2 (en)	1994-07-25
EP0165904A2 (de)	1985-12-27
BG60306B2 (bg)	1994-07-25
SU1436879A3 (ru)	1988-11-07
PL145104B1 (en)	1988-08-31
FI852399L (fi)	1985-12-21
PT80661B (en)	1987-05-04
BG60262B1 (bg)	1994-03-31
CS268672B2 (en)	1990-04-11
NO162467B (no)	1989-09-25
ES544344A0 (es)	1987-01-01
RO92583A (ro)	1987-11-30
PL254099A1 (en)	1986-09-09
DK170302B1 (da)	1995-07-31
BG60352B2 (bg)	1994-11-30
SU1482530A3 (ru)	1989-05-23
PL145348B1 (en)	1988-09-30
IE58070B1 (en)	1993-06-30
KR900008566B1 (ko)	1990-11-24
DK277685D0 (da)	1985-06-19
CS444985A2 (en)	1989-07-12
BG60262B2 (en)	1994-03-31
ES555539A0 (es)	1988-04-01
IE851520L (en)	1985-12-20
IL75546A0 (en)	1985-10-31
DE3582452D1 (de)	1991-05-16
IL75546A (en)	1990-01-18
NO162467C (no)	1990-01-10
PL145103B1 (en)	1988-08-31
JPH047746B2 (2)	1992-02-12
JPS6112688A (ja)	1986-01-21
PT80661A (en)	1985-07-01
CY1750A (en)	1994-06-03
BG60305B2 (bg)	1994-07-25
ES8800681A1 (es)	1987-11-16
BG60402B2 (bg)	1995-02-28
PL145087B1 (en)	1988-08-31
ES555541A0 (es)	1987-11-16
ES8702406A1 (es)	1987-01-01
AU4385785A (en)	1986-01-02
HU202529B (en)	1991-03-28
GR851487B (2)	1985-11-25
NO852474L (no)	1985-12-23
FI80694B (fi)	1990-03-30
SU1443802A3 (ru)	1988-12-07

Publication	Publication Date	Title
PL145814B1 (en)	1988-11-30	Method of obtaining novel condensed derivatives of double-ring imidazole
FI64376B (fi)	1983-07-29	Foerfarande foer framstaellning av en farmakologiskt anvaendbar 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol
US5169947A (en)	1992-12-08	3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
US4996210A (en)	1991-02-26	Heterocyclic spiro compounds and methods for preparing the same
AU757510B2 (en)	2003-02-20	Pyrrolobenzodiazepines
PL152025B1 (en)	1990-10-31	Alpha-heterocycle substituted tolunitriles
CZ280769B6 (cs)	1996-04-17	Derivát N-acyl-2,2-benzodiazepinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
CZ218298A3 (cs)	1999-08-11	Heterocyklický kondenzovaný morfiátový derivát (II), způsob jeho přípravy a použití
US5204337A (en)	1993-04-20	Estrogen nucleus derivatives for use in inhibition of sex steroid activity
EP2499151A2 (en)	2012-09-19	Mammalian metabolites of steroids
NZ195504A (en)	1984-12-14	Indolobenzoxazine derivatives and pharmaceutical compositions
US4180581A (en)	1979-12-25	N-9,10-dihydrolysergyl-m-aminobenzoic acid amide derivative
GB1569251A (en)	1980-06-11	Pyridobenzodiazepines
PL182747B1 (pl)	2002-02-28	Nowe pochodne morfiny ze skondensowanym pierścieniem heterocyklicznym i kompozycja farmaceutyczna je zawierająca
EA003941B1 (ru)	2003-10-30	2-аминопиридины, содержащие конденсированные кольца в качестве заместителей
IE903616A1 (en)	1991-04-24	Neuroprotectant Agents
US4707484A (en)	1987-11-17	Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
DK162050B (da)	1991-09-09	Pyrazolderivater med ergolinskelet eller salte deraf, deres fremstilling, farmaceutiske praeparater indeholdende disse og fremgangsmaade til fremstilling af de farmaceutiske praeparater
EA003991B1 (ru)	2003-12-25	Производные 2-аминопиридинов, способ ингибирования синтазы оксида азота, фармацевтические композиции и способы лечения
WO2014186325A1 (en)	2014-11-20	Processes and intermediates for preparing indole pharmaceuticals
US5374722A (en)	1994-12-20	Bridged benzazepines
US5929087A (en)	1999-07-27	Decahydroquinoline-based anti-cholinergic agents
JPH02221274A (ja)	1990-09-04	新規な誘導体類
FI71554B (fi)	1986-10-10	Foerfarande foer framstaellning av terapeutiskt anvaendbara 5- s-trans-amino-3,4,5,6-tetrahydro-1h-cyklohept/c d/indol- 6-lderivat och av deras syraadditionssalter
FI83079C (fi)	1991-05-27	Foerfarande foer framstaellning av terapeutiskt aktiva 5-fenyl-imidazo/1,5-a/ pyridiner.